A lthough perinatal HIV transmission is now a rare event in developed countries, as many as 40% of infants born to HIV-positive mothers still become infected in sub-Saharan Africa. 1 It has been estimated that 90% of the world's 2.1 million HIVinfected children lived in Africa at the beginning of 2004. 2 Although short-course antiretroviral drug regimens have made a major impact in the prevention of mother-to-child transmission of HIV (PMTCT), identification of HIV-infected women through voluntary counseling and testing (VCT) remains the critical first step. If the ambitious targets for PMTCT set forth by the United Nations General Assembly Special Session on HIV/AIDS are to be met, HIV testing acceptance must increase to nearly 100% by 2010. 3 The Lusaka District PMTCT Program was established in 2001, through partnerships between the Zambian Ministry of Health and the University of Alabama at Birmingham, and has expanded rapidly. 4 As of March 2006, the program had tested 140,000 patients, diagnosed more than 32,000 women with HIV, and dispensed nearly 28,000 courses of nevirapine prophylaxis. However, despite the wide availability of this PMTCT intervention, roughly one-fifth of pregnant women decline HIV testing. To reduce the proportion of women who refuse HIV testing and move toward the goal of achieving universal PMTCT coverage for all HIVpositive pregnant women, it is necessary to understand the factors related to testing acceptance.
Methods
In its first 3 years, the Lusaka District PMTCT Program expanded to all 24 district health centers and the University Teaching Hospital. The program utilizes an "opt-out" strategy for HIV counseling, followed by voluntary, "opt-in" HIV testing. Counseling is conducted via group talks and individual follow-up sessions; anecdotally, nearly all patients participate. Overall, 79% have agreed to HIV testing, but significant monthly variation is seen from clinic to clinic (40% to 97% in 2005).
This study was designed to identify predictive factors for accepting HIV testing among antenatal clinic attendees in this programmatic setting. We began with a series of focus group discussions to gain a qualitative understanding of why women refuse HIV testing. We organized five discussion groups, ranging in size from two to 14 participants, to qualitatively assess women's concerns regarding HIV counseling and testing. Women waiting for HIV counseling were randomly selected to participate. From these discussions, three themes were apparent: 1) that learning or knowing one's HIV status may negatively affect health; 2) that the counseling session was important in decisionmaking; and 3) that self-perceived risk played a large role in test acceptance. We incorporated these themes into a 49-question survey. A preliminary draft of the survey was field-tested on healthcare workers in a local facility. Wording and content were modified according to their recommendations.
This questionnaire was administered at four of Lusaka's 24 district health centers (Kalingalinga, Chelstone, Mtendere, and Kanyama clinics), selected by investigators as being representative of the Lusaka district. After pretest counseling in the antenatal clinic, women were approached by trained study personnel. The voluntary nature of participation was emphasized and written informed consent was obtained. Questionnaires were then administered in the participant's language of choice-English, Nyanja, or Bemba. Interviewers were blinded to the participant's decision regarding HIV testing. After completion of the questionnaire, answers were linked to the Lusaka District's screening registers, using the patient's coded identification number. We were thus able to obtain information on a respondent's decision to test and, if applicable, her HIV status. The sample size for this study was targeted at 1,000 participants. To attain proportional representation based on relative clinic size, staff members spent equal time at each of the four sites. The protocol and survey instrument were approved by the University of Zambia Research Ethics Committee prior to study activation.
Statistical analysis was performed using SAS version 9.0 (SAS Institute, Cary, North Carolina). Tests for general association were conducted using Pearson chi-square statistics. Fisher exact test was used to evaluate general association when the expected individual cell counts were small. Categories of predictors were further refined to produce fewer distinct homogeneous groupings with respect to the likelihood of testing. Because this survey was performed on a selected sample of clinics believed to be representative of the antenatal population structure in the Lusaka District, estimates that reflect the target population were unadjusted. However, to evaluate specific risk factors related to clinic level characteristics, Mantel-Haenszel relative risks (with 95% confidence intervals) were used to adjust for clinic. Breslow-Day tests were used evaluate whether the estimates of risk differed across clinics.
Results
From March to April 2003, 1064 antenatal attendees were approached about the study and 1060 (Ͼ99%) chose to participate. Of the 1,060 participants, 485 (46%) were from Kanyama clinic; 257 (24%) from Mtendere clinic; 185 (17%) from Chelstone clinic; and 135 (13%) from Kalingalinga clinic. Overall, 686 (65%) agreed to HIV testing, whereas 374 (35%) declined. The proportion of women who accepted HIV testing varied from 52% to 84% across the four sites (P Ͻ 0.0001). Table 1 shows the distribution of demographic characteristics among the study population and the proportion in each category that accepted HIV testing. In this univariate analysis, only the total number of pregnancies (P ϭ 0.04) and marital status (P ϭ 0.05) were marginally associated with testing based on our stratification categories.
Demographic Predictors of HIV Testing
We next evaluated respondent characteristics according to site and found significant differences in years of education, income level, and number of reported sexual partners (data not shown). Because the clinic of attendance was related to demographic characteristics and because clinic-level factors may independently affect testing rates, we controlled for site in a bivariate analysis. Several demographic characteristics were significantly, but weakly, associated with HIV test acceptance. Women were significantly more likely to agree to testing if they were younger than 20 years old (adjusted RR, 1.14; 95% CI, 1.04 -1.25); were pregnant with their first baby (adjusted RR, 1.14; 95% CI, 1.05-1.23); were currently unmarried (adjusted RR, 1.14; 95% CI, 1.02-1.28); had less than 7 years of education (adjusted RR, 1.15; 95% CI, 1.05-1.25); or earned less than 250,000 Zambian Kwacha (approximately US$ 50) per month (adjusted RR, 1.14; 95% CI, 1.03-1.25).
Influence of Health Care Setting
The clinic encounter appeared to influence a woman's decision to be tested as well (Table 2 ). In bivariate analysis, controlling for clinic-level variability, women who believed the counseling session to be influential (adjusted RR, 1.36; 95% CI, 1.23-1.51) and those who met the counselor for the first time (adjusted RR, 1.35; 95% CI, 1.13-1.61) were all more likely to agree to HIV testing. Overall, respondents reported a high level of trust in the ability of nurses and counselors to keep HIV test results confidential. Only a small proportion believed that clinical staff would betray this confidence either in the community (2%) or among other health care providers (5%). Nearly all participants saw the availability of antiretroviral drugs for infant prophylaxis (92%) as an incentive for HIV testing, though paradoxically, those women who acknowledged the importance of this incentive were less likely to accept testing when compared with others (63% vs. 74%; P ϭ 0.05). The vast majority (90%) also believed that accessible long-term antiretroviral therapy would encourage individuals to undergo testing for HIV. However, there were no noted differences between those who accepted testing and those who refused (91% vs. 89%; P ϭ 0.49). Respondents who stated a preference for counseling outside the clinic setting (22% overall) were less likely to accept testing when compared with others (51% vs. 68%; P Ͻ 0.0001). No additional differences were detected between acceptors and decliners of HIV testing with regard to the health care setting.
HIV and General Health
Eight hundred and thirty-four respondents (79%) believed that women who discover they are HIVinfected through testing will take better care of themselves after diagnosis. Despite this belief, the majority thought depression (84%) and more rapid disease progression (59%) would ensue after the diagnosis was made ( Table 2 ). The frequency of these perceptions did not vary significantly between those who elected to be tested and those who declined. When asked how long they believed an individual lives after infection with HIV, both groups reported relatively similar life expectancies (mean of 8.6 versus 9.1 years; P ϭ 0.26). When asked how long someone lives after the diagnosis of HIV, however, those who underwent testing were more likely to report lengthier survival (mean of 7.3 years versus 6.1 years; P ϭ 0.005).
HIV Testing and the Perception of Risk
Personal HIV risk also appeared to influence a woman's decision to be tested. Women reporting some level of personal risk were more likely to accept testing when compared to women with no reported risk (68% vs. 57%; P ϭ 0.001). When this at-risk group was further stratified into low-, moderate-, and high-risk categories, a negative correlation was seen between HIV testing and risk perception. Those with low self-perceived risk were most likely to accept testing (72%), but as self-perceived risk increased categorically, testing rates dropped (63% in the "moderate-risk" group and 54% in the "high-risk" group). This trend was found to be significant (P Ͻ 0.001).
Discussion
Antenatal HIV testing represents an important first step for family-based HIV care and a critical step for the prevention of perinatal HIV transmission. 5 Unfortunately, in areas such as sub-Saharan Africa, acceptance of VCT has traditionally been low. To increase these rates, it may first be necessary to learn why women agree to HIV testing.
Although this study has numerous strengths (e.g., large sample size, high response rate, breadth of topics covered), there are limitations that should be discussed. First, while we believe our target clinics to be representative in terms of patient volume, testing acceptance rates, and catchment area, they were few in number and not selected randomly. Use of more study clinics would have improved our ability to control for individual-level confounders and increased our confidence in the generalizability of these findings. A second limitation was our inability to compare the study participants with the general population of pregnant women seeking health care in the Lusaka public sector. Although we gathered detailed demographic information from each participant, parallel data were not available on a programmatic basis for a variety of reasons. We recognize that this inability to compare the two populations could lead to unidentified sources of bias. Lastly, because we focused our study on individual-level predictors, we were unable to control for facilitylevel factors (e.g., clinic size, staff numbers, community characteristics) that may have affected testing rates. As demonstrated by our results, clinic-and community-level factors appear influential in a woman's decision to undergo HIV testing. Despite these limitations, we believe there are important messages to be derived from this study. Like others, 6 -8 we found that first pregnancy, age younger than 20 years, unmarried status, low education attainment, and low monthly income were all related to increased rates of VCT acceptance. In our population, however, these individual-level demographic characteristics did not strongly predict HIV testing. Increased likelihood for testing was small, and targeted interventions based on these characteristics alone would probably result in only marginal increases in testing rates.
What may be more important is a woman's selfperception of HIV risk. Women who reported themselves to be at elevated risk for HIV were less likely to accept testing. The idea that HIV testing rates would decrease as risk perception increases may initially appear counterintuitive but likely reflects the denial surrounding HIV status among high-risk individuals, pervasive stigma associated the disease, and poor accessibility of antiretroviral therapy at time of this study. This finding is worrisome because risk estimation positively correlated with actual HIV-positive serostatus among those tested for HIV (though not statistically significant at the 0.05 level). A recent population surveillance of cord blood in Lusaka supports this notion: HIV prevalence was found to be significantly higher among decliners of HIV testing (29%) than among acceptors (24%; P Ͻ 0.0001) 9 ; other studies have described similar findings. 10, 11 In fact, we believe that self-perception of HIV risk could contribute to the association between certain demographic characteristics and increased VCT acceptance. Individuals who are younger, who are in their first pregnancy, or who have lower education attainment may have lower (though not completely absent) self-perceived risk for HIV. In this context, the purpose of VCT is to reassure these women about their HIV negative status, not to confirm suspicions of a positive result. Since this scenario is far less likely to generate apprehension and anxiety, it may explain the higher HIV testing rates. Although this line of thinking appears logical, further research is clearly needed to delineate this phenomenon.
One corollary to these findings was that 43% of women with no self-perceived HIV risk declined testing as well. Surprisingly, this figure approximated the rate of refusal among individuals with high self-perceived risk (46%). While the reasons for declining an HIV test may appear reasonable (e.g., women who believe they are not at risk may find testing unnecessary), given the high seroprevalence of HIV in the antenatal population, it is unlikely that the proportion of infected women would be dramatically lower. Unfortunately, given our study design, we are unable to determine the HIV seroprevalence in the subpopulation who refused testing. Nevertheless, focused counseling and education for these individuals could substantially increase the number of HIV-infected women identified.
Components of the health care setting also appeared to play a small, but significant, role in HIV test acceptance. In our study, women who met their counselor for the first time were more likely to test when compared to others. Those who refused VCT were more likely to support HIV testing outside the regular clinical setting. Taken together, these findings suggest that anonymity may be an important consideration for VCT settings, particularly given community misconceptions regarding HIV and stigma surrounding the disease. Other studies have reported similar phenomena. Van Dyk et al, 12 for example, found that 33% of surveyed patients would prefer to undergo VCT in a setting where no one would know them. Fylkesnes and Siziya 13 reported a nearly fivefold increase in VCT uptake when patients were given the choice of an "optional location" for testing, rather than the routine clinical setting.
Many community-level barriers described in the qualitative literature were also reiterated in our survey. 14 -16 For example, the belief that learning one's HIV status would lead to depression, rapid disease progression, and a hastened death was quite prevalent. There appeared to be a degree of apprehension regarding disclosure of HIV status, particularly if the result was positive. That these perceptions did not differ between acceptors and decliners of HIV testing was surprising.
These results suggest that a woman's decision to undergo HIV testing may be based less on personal beliefs about the disease and more on the feared social consequences of a positive diagnosis. Ultimately, community messages, household support, and clinic-level outreach may be needed to enable more women to undergo HIV testing. Interestingly, with the recent introduction of a district-level HIV treatment program in Lusaka, the availability of antiretroviral drugs has already had a strong effect on general HIV testing. Increased demand has been reported in many of the city's free-standing HIV testing sites and in district health centers. Further involvement of HIV-positive counselors and the establishment of HIV support groups may also positively influence a woman's decision to test.
In summary, testing acceptance varied widely among the study clinics. Although self-perceived risk does appear to influence a woman's decision to undergo HIV testing, we found few other individuallevel characteristics that were strongly predictive. Several community-level beliefs, including fears about the negative health effects of learning one's HIV status, were commonly held, and likely reduced testing on a community-level. Future work should concentrate on clinic-and community-level predictors for HIV testing. In addition, strategies for improving VCT uptake should focus on group counseling sessions, with emphasized involvement of partners and close family members. 17, 18 
